The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.
 
Ari Rosenberg
Consulting or Advisory Role - EMD Serono; Nanobiotix
 
Nishant Agrawal
No Relationships to Disclose
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I)
Consulting or Advisory Role - Prelude Therapeutics
 
Tanguy Y. Seiwert
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Innate Pharma; Merck; Nanobiotix; Roche Molecular Diagnostics
Research Funding - Bristol-Myers Squibb (Inst); Jounce Therapeutics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Innate Pharma; Merck; Nanobiotix; Roche Molecular Diagnostics
 
Zhen Gooi
No Relationships to Disclose
 
Elizabeth A. Blair
No Relationships to Disclose
 
Daniel Ginat
No Relationships to Disclose
 
Adam Howard
No Relationships to Disclose
 
Jeffrey Chin
No Relationships to Disclose
 
Sara Kochanny
No Relationships to Disclose
 
Evgeny Izumchenko
No Relationships to Disclose
 
Aditya Juloori
No Relationships to Disclose
 
Daniel J. Haraf
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals
Honoraria - Abbvie; Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Takeda (I)
Consulting or Advisory Role - Abbvie; Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Takeda (I)
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Lilly (Inst); Novartis
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis